Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic drug retail sales grow 30% during first half of 1995; hospital market is sluggish.

Executive Summary

GENERIC DRUG RETAIL SALES GROWTH OF 30% IN FIRST HALF OF 1995 compares with 50% in 1994, according to data presented by IMS International Senior VP Stephen Chappell at a Nov. 9-10 pharmaceutical conference sponsored by the Massachusetts Institute of Technology in Cambridge, Mass. The decrease is "not surprising" and "should not be viewed as an enormous slow-down in the generic market," Chappell remarked. He noted that the 1994 figures for the generics industry reflect the impact of a series of branded products going off patent in 1993 and 1994. In 1993, generic sales increased by 25%, Chappell noted.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027219

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel